Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake
Condition: Congestive Heart Failure Interventions: Drug: OPC-61815 injection 8 mg; Drug: OPC-61815 injection 16 mg Sponsor: Otsuka Pharmaceutical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials